Literature DB >> 3286330

Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage.

A A Young1, C Bogardus, D Wolfe-Lopez, D M Mott.   

Abstract

Six men with a low rate of insulin-stimulated, non-oxidative carbohydrate disposal (storage) and six with a high storage rate were recruited for study of the fate of insulin-stimulated glucose uptake. [3-3H]glucose was infused before and during a 4-h hyperinsulinemic euglycemic clamp procedure in a dosage regimen designed to maintain a constant specific activity. From the disposition of label, the rate of insulin-mediated glucose incorporation into glycogen in the low-storage subjects was one-fourth that of the high-storage subjects (P less than .02). The insulin-mediated increase in muscle glycogen synthase activity in the low-storage subjects was one-fourth that of the high-storage subjects (P less than .05), suggesting the possibility of a causal relationship. In the high-storage but not the low-storage subjects, the rate of glycolysis inferred from the appearance of metabolized tritium in body water exceeded the carbohydrate oxidation rate (P less than .002). This suggests that in these subjects there is a significant fraction of glycolysis that is not oxidized and that this component of carbohydrate metabolism therefore contributes to storage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286330     DOI: 10.2337/diab.37.3.303

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

Authors:  A W Thorburn; B Gumbiner; F Bulacan; P Wallace; R R Henry
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo.

Authors:  B Leighton; E Foot
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

4.  Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in nondiabetic pima indians are related To glycogen synthase fractional activity in cultured myoblasts.

Authors:  D M Mott; R E Pratley; C Bogardus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans.

Authors:  Y Kida; B L Nyomba; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  S Del Prato; R C Bonadonna; E Bonora; G Gulli; A Solini; M Shank; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.

Authors:  N Cohen; M Halberstam; P Shlimovich; C J Chang; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.